Ausmuco 750V Hataphar treats chronic respiratory diseases (2 blisters x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 2 blisters x 10 tablets
Ingredient Carbocisteine

Ingredient

Composition information	Content
Carbocisteine	750mg

Uses

indications

drugs are indicated in adults and children over 15 years old for treatment support in respiratory diseases with mucus secretion, including chronic respiratory obstruction.

Pharmacokic

ATC code: R05cb03.

Carbocistein has the effect of diluting the phlegm by cutting off the disulfures bridge crossing the cross chains of mucin peptides, which increases the viscosity of the secretion. This property reduces the mucus, changes the characteristics of sputum and helps to cough easily.

Dynamic pharmacokinetics

After drinking, Carbocistein absorbs quickly and reaches the maximum plasma concentration after 2 hours. Low bioavailability, less than 10% of the dose. The drug is strong and influenced by the liver for the first time. The sale time is about 2 hours.

drugs and metabolites are mainly excreted through the kidneys.

Before taking Ausmuco 750V Hataphar treats chronic respiratory diseases (2 blisters x 10 tablets)

How to use

Take oral use.

Dosage

Dosage: Take 1 capsule/time x 3 times/day. Should be reduced to 1 tablet/time x 2 times/day when there is a response.

What to do when overdose?

How to handle: In case of overdose, patients should be vomiting and vomiting. If not vomiting, should take regular measures, including gastric lavage.

What to do when forgetting a dose?

Side Effects

Gastrointestinal disorders:

Very common (ADR ≥ 1/10): Nausea, vomiting, gastrointestinal bleeding, stomach pain, diarrhea.

Skin and tissue disorders:

Rare (1/10000 ≤ ADR Instructions on how to handle ADR: Mild ADR should reduce the dose, severe ADR should stop the drug and treat symptoms.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

too hypersensitivity to any ingredients of the drug.

Patients with acute gastrointestinal ulcers.

Be cautious when used

Precautions when using drugs for patients with a history of stomach - duodenal ulcer or being used simultaneously with drugs that can cause gastrointestinal bleeding. If gastrointestinal bleeding patients should stop the drug.

Be cautious when taking medicine for the elderly.

Do not use medications at the same time as carbocistein.

Do not take overdue drugs.

The effect of the drug on driving and operating machinery

There is no evidence of the effect of the drug on driving and operating machinery.

Using drugs for women during pregnancy and lactation

Pregnancy:

Although studies in mammals have shown that the drug does not cause teratogenicity, Carbocistein is not recommended for use during pregnancy. Only use when really necessary.

Breastfeeding period:

Do not have enough information about the excretion of human milk, so it is necessary to be cautious when used for breastfeeding women.

Interactive drug

Interactive drugs: No reports.

Cavalry of the drug: Due to no studies on the correspondence of the drug, not mixing this drug with other drugs.

Storage

Leave a cool place, avoid light, temperatures below 30⁰C.

To be out of reach of children, read the instructions carefully before use.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.